These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14522886)

  • 1. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.
    Moreno-Bueno G; Sánchez-Estévez C; Cassia R; Rodríguez-Perales S; Díaz-Uriarte R; Domínguez O; Hardisson D; Andujar M; Prat J; Matias-Guiu X; Cigudosa JC; Palacios J
    Cancer Res; 2003 Sep; 63(18):5697-702. PubMed ID: 14522886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of differential gene expression in different stage human endometrial cancer].
    Wan XP; Cai B; Liu L; Xi XW; Yang YX
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):38-42. PubMed ID: 16635327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
    Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
    Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
    Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
    Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
    Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
    Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
    Romero-Pérez L; Castilla MÁ; López-García MÁ; Díaz-Martín J; Biscuola M; Ramiro-Fuentes S; Oliva E; Matias-Guiu X; Prat J; Cano A; Moreno-Bueno G; Palacios J
    Hum Pathol; 2013 Feb; 44(2):244-54. PubMed ID: 22974476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer.
    Risinger JI; Maxwell GL; Chandramouli GV; Jazaeri A; Aprelikova O; Patterson T; Berchuck A; Barrett JC
    Cancer Res; 2003 Jan; 63(1):6-11. PubMed ID: 12517768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.
    Cassia R; Moreno-Bueno G; Rodríguez-Perales S; Hardisson D; Cigudosa JC; Palacios J
    J Pathol; 2003 Dec; 201(4):589-95. PubMed ID: 14648662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
    Zheng M; Simon R; Mirlacher M; Maurer R; Gasser T; Forster T; Diener PA; Mihatsch MJ; Sauter G; Schraml P
    Am J Pathol; 2004 Jul; 165(1):63-9. PubMed ID: 15215162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser capture microdissection with genome-wide expression profiling displayed gene expression signatures in endometrioid endometrial cancer.
    Mokhtar NM; Ramzi NH; Yin-Ling W; Rose IM; Hatta Mohd Dali AZ; Jamal R
    Cancer Invest; 2012 Feb; 30(2):156-64. PubMed ID: 22122087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer.
    Chen Y; Yao Y; Zhang L; Li X; Wang Y; Zhao L; Wang J; Wang G; Shen D; Wei L; Zhao J
    Exp Mol Pathol; 2011 Aug; 91(1):373-84. PubMed ID: 21540026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
    Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
    Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
    Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients.
    Morrison C; Zanagnolo V; Ramirez N; Cohn DE; Kelbick N; Copeland L; Maxwell GL; Fowler JM
    J Clin Oncol; 2006 May; 24(15):2376-85. PubMed ID: 16710036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular carcinogenesis of endometrial cancer.
    Liu FS
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression and amplification of STK15 in human gliomas.
    Klein A; Reichardt W; Jung V; Zang KD; Meese E; Urbschat S
    Int J Oncol; 2004 Dec; 25(6):1789-94. PubMed ID: 15547718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast.
    Hoque A; Carter J; Xia W; Hung MC; Sahin AA; Sen S; Lippman SM
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1518-22. PubMed ID: 14693746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed chromosomal characterization of the breast cancer cell line MCF7 with special focus on the expression of the serine-threonine kinase 15.
    Klein A; Jung V; Zang KD; Henn W; Montenarh M; Kartarius S; Steudel WI; Urbschat S
    Oncol Rep; 2005 Jul; 14(1):23-31. PubMed ID: 15944763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.
    Choschzick M; Lebeau A; Marx AH; Tharun L; Terracciano L; Heilenkötter U; Jaenicke F; Bokemeyer C; Simon R; Sauter G; Schwarz J
    Hum Pathol; 2010 Mar; 41(3):358-65. PubMed ID: 19896697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.